Clik here to view.
Together for Safer Roads任命 David Braunstein担任总裁
华盛顿 (美国商业资讯)–全球私营公司联盟Together for Safer Roads (TSR)今日宣布，David Braunstein将于7月24日加入TSR担任总裁。Braunstein是一名资深的企业领导者，在私营行业的全球和新兴技术领域拥有丰富的经验。 TSR董事长兼百威英博(AB InBev)首席执行官 Carlos...
View ArticleClik here to view.
SpinalCyteが新たな日本国特許を取得
ヒューストン テキサスに拠点を置き、ヒト皮膚線維芽細胞を使用した椎間板髄核の再生に傾注する組織工学技術企業のSpinalCyte, LLCは本日、日本国特許第6151006号「生体内バイオリアクターを使用した軟骨修復のための方法と組成物」の登録を発表しました。...
View ArticleClik here to view.
美泰上市全球最先进的人参补剂
中国广州 (美国商业资讯) — 美泰® (NASDAQ: MTEX) 通过其网站www.MEITAICHINA.COM向中国家庭提供顶级品质的营养补剂，该公司宣布，GinMAX™片已在中国上市。GinMAX是一种强效的双层人参产品，属同类中首创。 这种独特的双层片剂采用世界上首款发酵白参Panax ginseng制造，并与强效发酵红参Panax...
View ArticleClik here to view.
Optibrium and Bugworks Sign Agreement for StarDrop License
CAMBRIDGE, United Kingdom & BENGALURU, India Optibrium™, a developer of software for small molecule discovery, and Bugworks Research Inc. (Bugworks), a company focused on discovering...
View ArticleClik here to view.
Co-Diagnostics, Inc. Announces Joint Venture in India
SALT LAKE CITY Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic...
View ArticleClik here to view.
Takeda and BioSurfaces Announce Joint Research Program to Explore Promising...
CAMBRIDGE & ASHLAND, Mass. Takeda Pharmaceutical Company Limited (TSE: 4502) and BioSurfaces Inc. announced today that they have entered into an agreement to initiate a research program designed...
View ArticleClik here to view.
Consolidated Financial Results for the First Quarter of 2017OMRON Boosts Net...
KYOTO, Japan OMRON Corporation (TOKYO: 6645) (HQ: Shimogyo-Ku, Kyoto, Japan. President and CEO: Yoshihito Yamada) today announced its consolidated operating results for the first quarter of fiscal...
View ArticleClik here to view.
Cogstate Receives Positive FDA Notification Regarding Medical Device...
BOSTON The cognitive science company, Cogstate today announced that its healthcare division has received notification from the U.S. Food and Drug Administration (FDA) that the Company’s 510(k)...
View ArticleClik here to view.
New CDISC Standard Empowers Smarter Research for Diabetic Kidney Disease
AUSTIN, Texas The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the availability of a new Therapeutic Area Standard for Diabetic Kidney Disease in the form of a User...
View ArticleClik here to view.
Astellas Reports First Quarter FY2017 Financial Results
TOKYO Astellas Pharma Inc. (TOKYO:4503)(President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced the financial results for the first quarter of fiscal year 2017 (“FY2017”), ending March...
View ArticleClik here to view.
Takeda Reports 1st Quarter FY2017 Results
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth of 6.6% led by Takeda’s Growth Drivers Underlying Revenue grew +6.6% with growth across all regions (U.S....
View ArticleClik here to view.
武田薬品: 2017年度第1四半期の連結業績について
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 （東証：4502）： 実質的な売上収益の成長は6.6％の増収、成長ドライバーが牽引...
View ArticleClik here to view.
Accenture Develops Artificial Intelligence-Powered Solution to Help Improve...
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 BANGALORE, India Accenture (NYSE: ACN) has developed a new artificial intelligence (AI)–powered solution to help the visually impaired...
View ArticleClik here to view.
武田公布2017财年第一季度业绩
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited)(TOKYO: 4502)： 武田增长引擎带动基础营收增长 6.6% 基础营收增长+6.6%，各地区业务均有所增长（美国+13.5%、日本 +1.6%、欧洲与加拿大 +4.6%、 新兴市场...
View ArticleClik here to view.
Study Compares Performance of Masimo Acoustic Respiration Rate (RRa®) and...
TOKYO Masimo (NASDAQ: MASI) announced today that researchers at the Tokyo Women’s Medical University, Department of Anesthesiology, in Japan have published a study investigating the measurement of...
View ArticleClik here to view.
FDA计划将香烟中的尼古丁降至非成瘾性水平，22nd Century Group因此受到世人瞩目
纽约州克拉伦斯 (美国商业资讯) – 专注于烟草减害的植物生物技术公司22nd Century Group, Inc. (NYSE American:XXII)今天表示，欢迎美国食品药品管理局(FDA)的通知，即依照《家庭吸烟预防和烟草管制法案》，该局有权责令在美国销售的可燃性香烟中尼古丁含量降至非成瘾性水平。 22nd Century已能够达到FDA雄心勃勃的新产品标准。按以往报道，22nd...
View ArticleClik here to view.
ボランティアの参加による研究でMasimo呼吸数（RRa®）とNellcorプレチスモグラフィー呼吸数の性能を比較
東京 （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、日本の東京女子医科大学麻酔科の研究者らが、ボランティアで呼吸数の測定について検討した研究の結果を公表したと発表しました。マシモのRadical-7® Pulse CO-Oximeter®を使用して測定したMasimo呼吸数（Masimo）と、Nellcor...
View ArticleClik here to view.
紙巻きたばこのニコチン含有量を中毒性のないレベルまで減らすFDAの計画は22ndセンチュリー・グループにスポットライトを当てる
米ニューヨーク州クラレンス （ビジネスワイヤ） — タバコの有害性低減に傾注する植物バイオテクノロジー企業の22ndセンチュリー・グループ（NYSE American:XXII）は本日、米食品医薬品局（FDA）が、「家庭内喫煙予防・たばこ規制法」に基づく権限を行使し、米国で販売される燃焼式紙巻きたばこのニコチンを中毒性のないレベルまで引き下げることを義務付ける計画発表を歓迎すると発表しました。...
View ArticleClik here to view.
Takeda and Cardurion Pharmaceuticals Launch Cardiovascular Development...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda Pharmaceutical Company Limited (TSE: 4502) and Cardurion Pharmaceuticals today announced the creation of a new cardiovascular development partnership....
View ArticleClik here to view.
A.M. Best Assigns Credit Ratings to Ping An Health Insurance Company of...
HONG KONG A.M. Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of “a-” to Ping An Health Insurance Company of China, Ltd. (Ping An Health)...
View Article